InvestorsHub Logo
Followers 2095
Posts 90210
Boards Moderated 0
Alias Born 12/17/2011

Re: None

Tuesday, 10/06/2020 7:56:15 AM

Tuesday, October 06, 2020 7:56:15 AM

Post# of 5639
OCGN...34...in the P/M...MALVERN, Pa., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced it has entered into an agreement with Kemwell Biopharma Pvt. Ltd. (Kemwell) to manufacture OCU200, Ocugen’s novel biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD).

Its is not about how much profit you make on a trade but how many profitable trades you are able to make...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News